Understanding and Transforming The U.S. Healthcare System B7227 - Fall 2020
Understanding and Transforming The U.S. Healthcare System B7227 - Fall 2020
Understanding and Transforming The U.S. Healthcare System B7227 - Fall 2020
Healthcare System
SUBJECT TO CHANGE
A. ADMINISTRATIVE INFORMATION
Contact Information
There is no textbook for this course. See assigned readings linked on Canvas. All cases are
available for purchase at the link specified on Canvas. At the start of each session, students
will be provided with a handout which accompanies slide presentations. Students may find
it useful to bring a notebook or other materials on which to take notes. Relevant materials
from each class will be posted on Canvas on the day after class.
Lecture Notes I will post the lecture slides on Canvas after each class, but note that the
slides are not a complete record of all that is discussed in class. It is recommended that you
take notes during the class as a supplement to the slides.
B. COURSE DESCRIPTION
The learning in this course will utilize, build on and extend concepts covered in the following core
courses:
Students will be expected to have mastered these concepts and be able to apply them in the course.
D. CLASS SCHEDULE
Guest speaker
Eric Galvin, President,
ConnectiCare
4 • Payers and payment systems: employers Reading
Oct 10 and policy GM Steers New Path On Health
• The history of employer-based health Benefits, The Wall Street Journal
insurance and recent trends Summary of the Affordable Care
• Characteristics of employer-sponsored Act, Kaiser Family Foundation
health coverage
• Employer strategies to control costs Success and Failure in the
and improve quality Insurance Exchanges, NEJM
• Workplace wellness
• The impact of the ACA on insurers and
employers Case study
Pitney Bowes: Employer Health
Strategy
Guest speaker
Marco Diaz, Board Chairman,
Northeast Business Group on
Health; SVP, Global Head of
Benefits, News Corp
5 Providers: hospitals and hospital systems Reading
Oct 17 • Hospital structure and strategies Hospitals: Origin, Organization and
• Organizational, financial, and human Performance, in Health Care USA,
resource issues and trends chapter 3
• Competitive forces and consolidation Evaluating the Impact of Health
• Cost, quality, and safety pressures Insurance Industry Consolidation,
Commonwealth Fund
Case study
The Dana-Farber Cancer Institute
6 Providers: new challenges for hospitals Reading
Oct 24 • Quality management practices in Healthy Business? Managerial
health care Education and Management in
• Process management and elimination Healthcare, HBS Working Paper
of waste
Case study
• Alignment of the hospital and its Virginia Mason Medical Center
clinicians (abridged)
Guest speaker
Brian Nester, CEO, Lehigh Valley
Hospital and Health Network
7 • Providers: physicians and practice Reading
Oct 31 variation The Cost Conundrum, The New
• Physician employment and practice Yorker
types
Reducing Practice Variation at
• Trends in physician practice
Crystal Run Healthcare, Health
• The quality “chasm,” spending
Affairs
discrepancies, and practice variation
• Implementing best practices and
moving from volume to value
8 Providers: alternative venues Reading
Nov 7 • Home health care When Wall Street Took Over This
• New models for caring for the high- Nursing Company, Profits Grew
need elderly population and Patients Suffered, Bloomberg
• Medicare PACE program The Importance of Transitional
• Medicare for All: lessons from dialysis Care in Achieving Health Reform,
Health Affairs
Case study
CareMore Health System
Fireside chat
Sunil Budhrani, CEO and CMO,
Innovation Health
9 Transformation in health systems Reading
Nov 14 • Medical homes, bundled payments, At Virginia Mason, Collaboration
and ACOs among Providers, Employers and
• Aligning with physicians Health Plans to Transform… Health
• Working with insurers and employers Affairs
• Social determinants of health Mayo’s Tricky Task: Revamp What
• Assuming risk and creating systems for Works, Wall Street Journal
population health
The Hot Spotters, The New Yorker
Case study
Intermountain Health Care
10 Intersections: pharmaceuticals and Reading
Nov 21 medical devices How Economics Can Shape
• The role of payers and providers in the Precision Medicines, Science
life sciences industries
Using Outcomes-Based Pricing for
• The challenges of precision medicine
Medical Devices to Improve
• Factors affecting adoption Cardiovascular Disease Treatment
• Policy and regulatory issues
Value, Health Affairs
• Opportunities and challenges
Guest speaker
Efrem Kamen, Founder, Pura Vida
Investments; Adjunct Assistant
Professor, Columbia GSB
Grading will be based on participation (20%), case write-ups (40%), and a final project (40%).
Class participation will be based on attendance (with the exception of students taking the course
asynchronously), as well as the extent and quality of contributions to class discussions. In-class
discussions are an integral part of the course, and students are expected to contribute to the learning
experience of the class by asking relevant questions and offering insights into the topic at hand.
Quality of contribution matters (much) more than quantity. However, students should feel free –
indeed obliged – to ask clarifying questions when they are not following what is happening in lecture.
Particularly important to the participation grade will be students’ participation during days when we
analyze case studies.
You will be expected to submit eight (of ten) written assignments. The reports will address specific
questions that will be available on Canvas and should be no more than one page. Each is due
electronically before class and will form the basis of some of the class discussion. Even if you do not
submit a written assignment, you will be expected to have read the assigned material and be able to
discuss it. Late assignments will not be accepted unless there is an exceptional circumstance. Under
the business school designation, these assignments are Type B. You may discuss the assignments in
groups, but you must hand in your own individually written report. Grades will be assigned on an
individual basis and the grade will be out of a maximum of 10 points. Only the first eight submissions
will be graded. You can expect cold calling will be used for these assignments and responses will
count towards your class participation grade.
The final project is a group project with a maximum of four students per group. There are several
options for the final project. You are asked to submit a 15 (max) page report that takes a deeper
dive into any of the topics that we covered in class (or missed in class). It is a good idea to mention
your proposed question/idea to me ahead of time (either by email, before/after class, or during
office hours). You are also encouraged to talk directly with a relevant company (or companies) in
1. Select a health system that has altered its investment or partnership strategy in response to
the Covid-19 pandemic. Drawing on the material from this course, evaluate the pros and
2. Analyze a firm whose business model hinges on one of the payment or delivery reforms
discussed in this course. For example, ACOs or PCMHs. How should such a firm grow?
3. Analyze the entry of private equity into a healthcare market. (There are numerous recent
examples.) What opportunities did investors identify? How has the delivery of healthcare
4. Evaluate a policy or regulation proposal with implications for the behavior and profitability
of the market participants documented in this course. What is the pain point this proposal
attempts to address? Does it create winners and losers? Do you think it will succeed? Why
or why not?
Honor Code
This course will strictly adhere to the academic conduct guidelines discussed in detail at
http://www0.gsb.columbia.edu/honor/resources.html.